EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients

Becky M Ma, Naama Elefant, Martina Tedesco, Kelsie Bogyo, Natalie Vena, Sarath K Murthy, Shiraz A Bheda, Sandy Yang, Nikita Tomar, Jun Y Zhang, Syed Ali Husain, Sumit Mohan und 3 weitere

Kidney International · 2024-07 · 106 (1) · 115-125

DOI: 10.1016/j.kint.2024.02.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2024-07. Verfasst von Becky M Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA; Department of…. Hauptthemen laut MEDLINE: Kidney Transplantation, Genetic Testing, Exome Sequencing. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Natera Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease, infection, malignancy, and thromboembolism are major causes of morbidity and mortality in kidney transplant recipients (KTR). Prospectively identifying monogenic conditions associated with post-transplant complications may enable personalized management. Therefore, we developed a transplant morbidity panel (355 genes) associated with major post-transplant complications including cardiometabolic disorders, immunodeficiency, malignancy, and thrombophilia. This gene panel was then evaluated using exome sequencing data from 1590 KTR. Additionally, genes associated with monogenic kidney and genitourinary disorders along with American College of Medical Genetics (ACMG) secondary findings v3.2 were annotated. Altogether, diagnostic variants in 37 genes associated with Mendelian kidney and genitourinary disorders were detected in 9.9% (158/1590) of KTR; 25.9% (41/158) had not been clinically diagnosed. Moreover, the transplant morbidity gene panel detected diagnostic variants for 56 monogenic disorders in 9.1% KTRs (144/1590). Cardiovascular disease, malignancy, immunodeficiency, and thrombophilia variants were detected in 5.1% (81), 2.1% (34), 1.8% (29) and 0.2% (3) among 1590 KTRs, respectively. Concordant phenotypes were present in half of these cases. Reviewing implications for transplant care, these genetic findings would have allowed physicians to set specific risk factor targets in 6.3% (9/144), arrange intensive surveillance in 97.2% (140/144), utilize preventive measures in 13.2% (19/144), guide disease-specific therapy in 63.9% (92/144), initiate specialty referral in 90.3% (130/144) and alter immunosuppression in 56.9% (82/144). Thus, beyond diagnostic testing for kidney disorders, sequence annotation identified monogenic disorders associated with common post-transplant complications in 9.1% of KTR, with important clinical implications. Incorporating genetic diagnostics for transplant morbidities would enable personalized management in pre- and post-transplant care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGenetic TestingExome SequencingHumansFemaleMaleAdultMiddle AgedPostoperative ComplicationsTransplant RecipientsAgedGenetic Predisposition to Disease

Stichwörter der Autor:innen

diagnosticsexome sequencingkidney transplantationprecision medicine

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA; Department of Medicine, Center for Precision Medicine and Genomics, Columbia Univer…
  • Division of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, New York, USA.

Förderung

  • NIDDK NIH HHS
  • Natera Inc

Zitieren

APA

Ma, B. M., Elefant, N., Tedesco, M., Bogyo, K., Vena, N., Murthy, S. K., Bheda, S. A., Yang, S., Tomar, N., Zhang, J. Y., Husain, S. A., Mohan, S., Kiryluk, K., Rasouly, H. M., & Gharavi, A. G. (2024). Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney International, 106(1), 115-125. https://doi.org/10.1016/j.kint.2024.02.021

Vancouver

Ma BM, Elefant N, Tedesco M, Bogyo K, Vena N, Murthy SK, et al. Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients. Kidney International. 2024;106(1):115-125. doi:10.1016/j.kint.2024.02.021

BibTeX
@article{Ma2024,
  author = {Ma, Becky M and Elefant, Naama and Tedesco, Martina and Bogyo, Kelsie and Vena, Natalie and Murthy, Sarath K and Bheda, Shiraz A and Yang, Sandy and Tomar, Nikita and Zhang, Jun Y and Husain, Syed Ali and Mohan, Sumit and Kiryluk, Krzysztof and Rasouly, Hila Milo and Gharavi, Ali G},
  title = {Developing a genetic testing panel for evaluation of morbidities in kidney transplant recipients},
  journal = {Kidney International},
  year = {2024},
  volume = {106},
  number = {1},
  pages = {115--125},
  doi = {10.1016/j.kint.2024.02.021}
}
Kostenlos starten →